Le Lézard
Classified in: Health
Subjects: PDT, MAT

BTL AESTHETICS INTRODUCES A NEW EMSCULPT NEO EDGEtm APPLICATOR FOR THE LATERAL ABDOMEN


The latest launch further positions the body shaping therapy as the most expansive treating non-invasive contouring device on the market, capturing all major bodily regions.

NEW YORK, July 12, 2022 /PRNewswire/ -- BTL, the authority in non-invasive body sculpting therapies, continues to build upon the success of its game-changing Emsculpt NEO treatment with the launch of the new Edgetm Applicators. What differentiates the Edge applicator is the coverage spread over the entire lateral abdomen. Shipping will commence in September 2022.

Sleekly designed to allow for a better contour of the curvy areas of the body, such as the lateral abdomen, the Edge applicator utilizes radiofrequency and HIFEMTM technology to simultaneously address fat deposits and muscle groups in the lateral abdomen region. Further, the new device extension tones the oblique muscles when treating the lateral abdomen, and many patients experience a significant improvement in their posture, core, and back discomfort.

According to Ron Borsheim, Vice President of Product Development, "With the exciting new addition of the Edge applicator, BTL is continuing to raise the bar in the aesthetics industry and innovate for versatility by extending the sculpting power of the award-winning Emsculpt NEO therapy. The unrivaled device treats more key muscle groups than any other non-invasive treatment."

When launched in 2018, the Emsculpt therapy was the world's first and only treatment to use HIFEM technology to build muscle and sculpt the body in a 30-minute session. Emsculpt NEO, launched in 2020, expanded upon its predecessor's capabilities by simultaneously delivering heat and magnetic energy. The result is more fat reduction and more muscle growth than any single gold standard product. Clinical studies have shown that, on average, patients experience a 30% fat reduction and a 25% increase in muscle in the treated area. With over 1 million treatments administered to date, Emsculpt Classic and Emsculpt NEO continue to be gold-standard solutions in non-invasive body contouring therapies.

For more information on Emsculpt NEO and BTL Aesthetics, please visit www.bodybybtl.com.

ABOUT BTL AESTHETICS

Founded in 1993, BTL has grown to become one of the world's major medical and aesthetic equipment manufacturers. With 2,400 employees located in more than 65 countries, BTL has revolutionized the way to offer the most advanced non-invasive solutions for body shaping, skin tightening & other medical aesthetic treatments, including women's intimate health and wellness. BTL's brands include EMSCULPT NEO, EMSCULPT, EMSELLA, EMTONE, EMFEMME, EMFACE, and BTL Exilis ULTRA. Additional information can be found at www.bodybybtl.com.

FOR ALL MEDIA INQUIRIES AND REQUESTS, PLEASE REACH OUT TO:

Nouveau Communications
[email protected]

SOURCE BTL Aesthetics


These press releases may also interest you

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...



News published on and distributed by: